COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CRI - FR0000130692 - Common Stock
10.22 EUR
-0.08 (-0.78%)
Taking everything into account, CRI scores 3 out of 10 in our fundamental rating. CRI was compared to 16 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- CRI had positive earnings in the past year.
- In the past year CRI had a positive cash flow from operations.
- Of the past 5 years CRI 4 years were profitable.
- In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
- CRI has a worse Return On Assets (0.28%) than 68.75% of its industry peers.
- CRI has a worse Return On Equity (1.03%) than 68.75% of its industry peers.
- The Return On Invested Capital of CRI (5.14%) is better than 62.50% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for CRI is in line with the industry average of 6.39%.
- The last Return On Invested Capital (5.14%) for CRI is above the 3 year average (4.65%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.14% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
- Looking at the Profit Margin, with a value of 0.37%, CRI is doing worse than 68.75% of the companies in the same industry.
- CRI's Profit Margin has declined in the last couple of years.
- With a Operating Margin value of 6.41%, CRI perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
- CRI's Operating Margin has been stable in the last couple of years.
- With a Gross Margin value of 28.51%, CRI is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
- The number of shares outstanding for CRI has been increased compared to 1 year ago.
- CRI has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.24, we must say that CRI is in the distress zone and has some risk of bankruptcy.
- CRI has a worse Altman-Z score (1.24) than 81.25% of its industry peers.
- CRI has a debt to FCF ratio of 124.09. This is a negative value and a sign of low solvency as CRI would need 124.09 years to pay back of all of its debts.
- CRI has a worse Debt to FCF ratio (124.09) than 68.75% of its industry peers.
- A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
- CRI has a worse Debt to Equity ratio (1.38) than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Altman-Z | 1.24 |
ROIC/WACC0.79
WACC6.47%
2.3 Liquidity
- CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.30, CRI is doing worse than 87.50% of the companies in the same industry.
- A Quick Ratio of 0.86 indicates that CRI may have some problems paying its short term obligations.
- With a Quick ratio value of 0.86, CRI is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.24%, which is quite impressive.
- The earnings per share for CRI have been decreasing by -14.59% on average. This is quite bad
- CRI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.67%.
- The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
- Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 32.19% on average per year.
- Based on estimates for the next years, CRI will show a small growth in Revenue. The Revenue will grow by 3.45% on average per year.
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 78.62, the valuation of CRI can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of CRI indicates a slightly more expensive valuation: CRI is more expensive than 68.75% of the companies listed in the same industry.
- CRI is valuated expensively when we compare the Price/Earnings ratio to 26.94, which is the current average of the S&P500 Index.
- CRI is valuated correctly with a Price/Forward Earnings ratio of 13.40.
- Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than 75.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.94, CRI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.62 | ||
| Fwd PE | 13.4 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than 75.00% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, CRI is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.82 | ||
| EV/EBITDA | 7.34 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CRI's earnings are expected to grow with 32.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.4%
EPS Next 3Y32.19%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.28%, CRI has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 3.08, CRI is paying slightly less dividend.
- CRI's Dividend Yield is slightly below the S&P500 average, which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.28% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 118.52% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPA:CRI (1/20/2026, 7:00:00 PM)
10.22
-0.08 (-0.78%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-05 2025-11-05
Earnings (Next)02-11 2026-02-11/amc
Inst Owners4.68%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap254.38M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target11.56 (13.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.28% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-43.78%
EPS NY rev (3m)-58.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.62 | ||
| Fwd PE | 13.4 | ||
| P/S | 0.35 | ||
| P/FCF | 74.82 | ||
| P/OCF | 10.69 | ||
| P/B | 0.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.34 |
EPS(TTM)0.13
EY1.27%
EPS(NY)0.76
Fwd EY7.46%
FCF(TTM)0.14
FCFY1.34%
OCF(TTM)0.96
OCFY9.36%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROCE | 7.02% | ||
| ROIC | 5.14% | ||
| ROICexc | 6.13% | ||
| ROICexgc | 13.12% | ||
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% | ||
| FCFM | 0.47% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Debt/EBITDA | 4.67 | ||
| Cap/Depr | 66.89% | ||
| Cap/Sales | 2.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.87% | ||
| Profit Quality | 125.93% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.24 |
F-Score7
WACC6.47%
ROIC/WACC0.79
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year104.23%
EBIT Next 3Y38.23%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for CRI stock?
The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 78.62 and the Price/Book (PB) ratio is 0.97.
How financially healthy is COMPAGNIE CHARGEURS INVEST?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.